Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Ottawa
$105,000.00
Assessing the effectiveness of a multi-component contingency management intervention for substance use disorders in a Schizophrenia Outpatient Program
EF 2023-24
Résumé
Substance use disorders (SUD) are highly prevalent among people with schizophrenia, with approximately 40-50% of individuals having a lifetime diagnosis of at least one SUD. The most commonly diagnosed SUDs in this population include: cannabis, nicotine and stimulant use disorders. Compared to individuals with schizophrenia who do not have a SUD, those who do struggle with a SUD are more likely to have increased symptoms of psychosis and depression, increased rates of re-hospitalization, and an increased risk of suicide. Unfortunately, traditional psychosocial treatments used to treat SUD have limited effectiveness when applied to this population. Due to a clinical need for integrated addiction and mental health care for individuals with schizophrenia, the use of contingency management (CM) -a psycho-social intervention - will be explored as part of my doctoral research. Given that cannabis use disorder is highly prevalent amongst individuals living with schizophrenia, the primary research objective will be to examine the effect of CM in helping individuals with schizophrenia decrease or stop their cannabis use. The secondary objective will be to explore the patient experience of the CM intervention. A mixed-methods design will be used to meet these objectives, where the quantitative portion will be given higher priority. This research will provide high-quality, evidence-based information needed to help improve mental health service delivery by supporting innovative approaches to SUD treatment for individuals with schizophrenia. This work will be implemented at The Royal, a tertiary mental health hospital that provides specialized assessment and treatment of schizophrenia, making it the first hospital of its kind in Canada to offer this service. This research will not only add to the body of knowledge on the use of CM in schizophrenia, but it will also inform how tertiary mental health hospitals in Canada can offer this intervention to their patients.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
497349
Name
Abebe Natania
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Assessing the effectiveness of a multi-component contingency management intervention for substance use disorders in a Schizophrenia Outpatient Program
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cannabis; Contingency Management; Psychosocial Treatment; Schizophrenia; Substance Use Disorder
Abstract
Substance use disorders (SUD) are highly prevalent among people with schizophrenia, with approximately 40-50% of individuals having a lifetime diagnosis of at least one SUD. The most commonly diagnosed SUDs in this population include: cannabis, nicotine and stimulant use disorders. Compared to individuals with schizophrenia who do not have a SUD, those who do struggle with a SUD are more likely to have increased symptoms of psychosis and depression, increased rates of re-hospitalization, and an increased risk of suicide. Unfortunately, traditional psychosocial treatments used to treat SUD have limited effectiveness when applied to this population. Due to a clinical need for integrated addiction and mental health care for individuals with schizophrenia, the use of contingency management (CM) -a psycho-social intervention - will be explored as part of my doctoral research. Given that cannabis use disorder is highly prevalent amongst individuals living with schizophrenia, the primary research objective will be to examine the effect of CM in helping individuals with schizophrenia decrease or stop their cannabis use. The secondary objective will be to explore the patient experience of the CM intervention. A mixed-methods design will be used to meet these objectives, where the quantitative portion will be given higher priority. This research will provide high-quality, evidence-based information needed to help improve mental health service delivery by supporting innovative approaches to SUD treatment for individuals with schizophrenia. This work will be implemented at The Royal, a tertiary mental health hospital that provides specialized assessment and treatment of schizophrenia, making it the first hospital of its kind in Canada to offer this service. This research will not only add to the body of knowledge on the use of CM in schizophrenia, but it will also inform how tertiary mental health hospitals in Canada can offer this intervention to their patients.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Abebe, Natania
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~